Quantum Wealth Summary


  • The pharmaceutical industry offers fast potential growth and defensive characteristics.
  • Healthcare sector stocks in the US have grown 47% over the last three years — and there could be more to come.
  • We see tailwinds for this industry in developed markets with ageing populations. Pharmaceuticals can offer high margins and an abnormal return on capital.
  • In this report, we compare two companies with unique propositions. Could breakthroughs in research and development speed up growth?
  • As a bonus: we also reveal our Weekly Top 5 Quantum Trends. These are the most impactful global opportunities that we are currently watching this week.



Had you bought BioNTech [NASDAQ:BNTX] stock before the pandemic, you’d have done rather well.

In early March 2020, when Covid-19 was spreading around the world and travel was being suspended, BioNTech’s share price sat at around US $30.

By August 2021, when the Pfizer/BioNTech vaccine had established itself as one of the most widely used vaccines, the BioNTech share price hit $389.

A 1,300% return in just over a year.

This demonstrates the power of an emerging pharmaceutical business. When R&D leads to a product that meets a need. And gets approval.

Patents on such products may serve to protect that intellectual property for up to 20 years.

I covered BioNTech’s story and potential future back in April. You can access that in our Exclusive Members Area.


Get started and receive your first Quantum Wealth Report today:

⚡🌎 LIMITED TIME OFFER: US$1 for 4 Weeks

⚡🌎 LIMITED TIME OFFER: NZ$1.50 for 4 Weeks